Top Markets
Coin of the day
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Rangering i aksjer #84
Abbott Laboratories, together with its subsidiaries, discovers, develops,... Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Aksjekurs
$101.91
Markedsverdi
$177.09B
Endring (1 dag)
-1.97%
Endring (1 år)
-19.78%
Land
US
Handel Abbott Laboratories (ABT)

Kategori

Driftsmargin for Abbott Laboratories (ABT)
Driftsmargin per April 2026 TTM: 18.16%
Ifølge Abbott Laboratories sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 18.16%. Ved slutten av 2024 hadde selskapet en driftsmargin på 16.27%.
Historikk for driftsmargin for Abbott Laboratories fra 2000 til 2026
Driftsmargin ved slutten av hvert år
År Driftsmargin Endre
2026 (TTM) 18.16% 0.00%
2025 18.16% 11.62%
2024 16.27% 1.43%
2023 16.04% -16.28%
2022 19.16% -10.30%
2021 21.36% 39.70%
2020 15.29% 6.25%
2019 14.39% 14.48%
2018 12.57% 74.58%
2017 7.20% -53.79%
2016 15.58% 7.82%
2015 14.45% 0.35%
2014 14.40% 46.64%
2013 9.82% 95.23%
2012 5.03% -71.44%
2011 17.61% -12.17%
2010 20.05% -6.13%
2009 21.36% 3.59%
2008 20.62% 8.07%
2007 19.08% -1.09%
2006 19.29% -7.30%
2005 20.81% -1.98%
2004 21.23% 40.50%
2003 15.11% -15.21%
2002 17.82% 53.22%
2001 11.63% -52.99%
2000 24.74% 0.00%
Driftsmargin for lignende selskaper eller konkurrenter
Selskap Driftsmargin Forskjell i driftsmargin Land
22.44% -98.76%
US
17.86% -99.02%
IE
17.86% -99.02%
IE
19.78% -98.91%
US
14.72% -99.19%
DE
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.